Edit this postCan Ion Exchange Maintain Its Double-Digit Growth as Roha Plant Scales Up?
About Ion Exchange (India) Ltd
Ion Exchange (India) Ltd is a leading water treatment and specialty chemicals company offering comprehensive solutions across industrial, municipal, and institutional segments. The company operates through its key divisions — Chemicals, Engineering, and Consumer Products — and continues to invest in advanced technology and backward integration for efficiency improvement.
Q2 FY26 showcased stable growth momentum, with both divisions contributing meaningfully to revenues. The ongoing Roha plant commissioning marks a critical milestone toward long-term capacity expansion and improved cost competitiveness.
Financial Highlights (Q2 FY26)
| Division | Revenue (₹ Mn) | YoY Growth | Remarks |
|---|---|---|---|
| Chemicals | 2,184 | +11% | Stable margins |
| Engineering | 4,562 | +16% | Execution-led |
| Order Book | 27,110 | — | Strong backlog |
| Order Inflow | 4,700 | — | Healthy wins |
Chemical Division: Revenue ₹2,184 Mn (+11% YoY) with stable margins despite input cost volatility. Roha plant ramp-up to drive capacity growth over 3–4 years.
Engineering Division: Revenue ₹4,562 Mn (+16% YoY), aided by improved project execution and strong service contracts.
Order Book ₹27,110 Mn and pipeline of ₹9,111 Cr provide strong visibility into FY27.
Stay tuned to near-term momentum via Nifty Futures Strategy Tip.
Operational Update & Capex Outlook
| Project / Metric | Details | Timeline |
|---|---|---|
| Roha Plant Capex | ₹425 Cr | Partial commissioning started Sept’25 |
| Utilization | 25% in first year | Gradual scale-up over 3–4 years |
| Depreciation Impact (FY27) | ~₹30 Cr | Due to capitalization phase |
| Partnership | Manhum Water (China) | Local UF & MBR membrane manufacturing in Goa |
The company expects double-digit revenue growth to continue through FY27, driven by capex benefits and robust order execution in water treatment projects.
Strengths & Weaknesses
Strengths
|
Weaknesses
|
The company’s chemical expansion and new partnerships are set to improve margin resilience once legacy projects conclude by FY26-end.
Opportunities & Threats
|
|
Ion Exchange’s combination of stable chemical growth, improving engineering execution, and strategic technology partnerships positions it for sustainable multi-year expansion.
Valuation & Investment View
- Short-term: Stable growth momentum; gradual margin recovery expected by FY26-end.
- Medium-term: Volume ramp-up from Roha plant to lift profitability metrics.
- Long-term: Strong project visibility and backward integration ensure structural growth.
For capital goods and utilities tracking, refer to BankNifty Futures Insight.
Investor Takeaway
Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, notes that Ion Exchange’s clear capacity roadmap, strong order book, and healthy margins make it a long-term play in the industrial water treatment and chemical solutions segment. Explore more such insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Related Queries on Industrial Stocks
- Will Roha expansion improve Ion Exchange’s margins in FY27?
- How is Ion Exchange’s order pipeline shaping up post Q2 FY26?
- What is the impact of the Manhum Water partnership on cost efficiency?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
